BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 33889513)

  • 1. Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma.
    Patiño-García A; Guruceaga E; Segura V; Sánchez Bayona R; Andueza MP; Tamayo Uria I; Serrano G; Fusco JP; Pajares MJ; Gurpide A; Ocón M; Sanmamed MF; Rodriguez Ruiz M; Melero I; Lozano MD; de Andrea C; Pita G; Gonzalez-Neira A; Gonzalez A; Zulueta JJ; Montuenga LM; Pio R; Perez-Gracia JL
    Transl Lung Cancer Res; 2021 Mar; 10(3):1327-1337. PubMed ID: 33889513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma.
    Patiño-García A; Guruceaga E; Andueza MP; Ocón M; Fodop Sokoudjou JJ; de Villalonga Zornoza N; Alkorta-Aranburu G; Uria IT; Gurpide A; Camps C; Jantus-Lewintre E; Navamuel-Andueza M; Sanmamed MF; Melero I; Elgendy M; Fusco JP; Zulueta JJ; de-Torres JP; Bastarrika G; Seijo L; Pio R; Montuenga LM; Hernáez M; Ochoa I; Perez-Gracia JL
    EBioMedicine; 2024 Apr; 102():105048. PubMed ID: 38484556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer.
    Fusco JP; Pita G; Pajares MJ; Andueza MP; Patiño-García A; de-Torres JP; Gurpide A; Zulueta J; Alonso R; Alvarez N; Pio R; Melero I; Sanmamed MF; Rodriguez Ruiz M; Gil-Bazo I; Lopez-Picazo JM; Casanova C; Baz Davila R; Agudo A; Lozano MD; Gonzalez A; Sala N; Ardanaz E; Benitez J; Montuenga L; Gonzalez-Neira A; Perez-Gracia JL
    Cancer Med; 2018 Jul; 7(7):3474-3483. PubMed ID: 29766673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligogenic germline mutations identified in early non-smokers lung adenocarcinoma patients.
    Renieri A; Mencarelli MA; Cetta F; Baldassarri M; Mari F; Furini S; Piu P; Ariani F; Dragani TA; Frullanti E
    Lung Cancer; 2014 Aug; 85(2):168-74. PubMed ID: 24954872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples.
    Bonfiglio S; Vanni I; Rossella V; Truini A; Lazarevic D; Dal Bello MG; Alama A; Mora M; Rijavec E; Genova C; Cittaro D; Grossi F; Coco S
    BMC Cancer; 2016 Aug; 16(1):692. PubMed ID: 27578032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples.
    Hintzsche J; Kim J; Yadav V; Amato C; Robinson SE; Seelenfreund E; Shellman Y; Wisell J; Applegate A; McCarter M; Box N; Tentler J; De S; Robinson WA; Tan AC
    J Am Med Inform Assoc; 2016 Jul; 23(4):721-30. PubMed ID: 27026619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Germline Mutations in East-Asian Young Never-Smokers with Lung Adenocarcinoma by Whole-Exome Sequencing.
    Fu F; Tao X; Jiang Z; Gao Z; Zhao Y; Li Y; Hu H; Shen L; Sun Y; Zhang Y
    Phenomics; 2023 Apr; 3(2):182-189. PubMed ID: 37197646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma: A case report.
    Vanni I; Coco S; Bonfiglio S; Cittaro D; Genova C; Biello F; Mora M; Rossella V; Dal Bello MG; Truini A; Banelli B; Lazarevic D; Alama A; Rijavec E; Barletta G; Grossi F
    Medicine (Baltimore); 2016 Nov; 95(48):e5447. PubMed ID: 27902597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-Exome Sequencing Identifies a Variant in Phosphatidylethanolamine N-Methyltransferase Gene to be Associated With Lean-Nonalcoholic Fatty Liver Disease.
    Bale G; Vishnubhotla RV; Mitnala S; Sharma M; Padaki RN; Pawar SC; Duvvur RN
    J Clin Exp Hepatol; 2019; 9(5):561-568. PubMed ID: 31695245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.
    Garofalo A; Sholl L; Reardon B; Taylor-Weiner A; Amin-Mansour A; Miao D; Liu D; Oliver N; MacConaill L; Ducar M; Rojas-Rudilla V; Giannakis M; Ghazani A; Gray S; Janne P; Garber J; Joffe S; Lindeman N; Wagle N; Garraway LA; Van Allen EM
    Genome Med; 2016 Jul; 8(1):79. PubMed ID: 27460824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.
    Kadara H; Choi M; Zhang J; Parra ER; Rodriguez-Canales J; Gaffney SG; Zhao Z; Behrens C; Fujimoto J; Chow C; Yoo Y; Kalhor N; Moran C; Rimm D; Swisher S; Gibbons DL; Heymach J; Kaftan E; Townsend JP; Lynch TJ; Schlessinger J; Lee J; Lifton RP; Wistuba II; Herbst RS
    Ann Oncol; 2017 Jan; 28(1):75-82. PubMed ID: 27687306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole exome re-sequencing implicates CCDC38 and cilia structure and function in resistance to smoking related airflow obstruction.
    Wain LV; Sayers I; Soler Artigas M; Portelli MA; Zeggini E; Obeidat M; Sin DD; Bossé Y; Nickle D; Brandsma CA; Malarstig A; Vangjeli C; Jelinsky SA; John S; Kilty I; McKeever T; Shrine NR; Cook JP; Patel S; Spector TD; Hollox EJ; Hall IP; Tobin MD
    PLoS Genet; 2014 May; 10(5):e1004314. PubMed ID: 24786987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of germline mutations in smokers and non-smokers in Brazilian non-small-cell lung cancer (NSCLC) patients.
    Couto PP; Bastos-Rodrigues L; Schayek H; Melo FM; Lisboa RGC; Miranda DM; Vilhena A; Bale AE; Friedman E; De Marco L
    Carcinogenesis; 2017 Oct; 38(11):1112-1118. PubMed ID: 28968711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
    Emond MJ; Louie T; Emerson J; Chong JX; Mathias RA; Knowles MR; Rieder MJ; Tabor HK; Nickerson DA; Barnes KC; ; Go L; Gibson RL; Bamshad MJ
    PLoS Genet; 2015 Jun; 11(6):e1005273. PubMed ID: 26047157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
    Rasnic R; Brandes N; Zuk O; Linial M
    BMC Cancer; 2019 Aug; 19(1):783. PubMed ID: 31391007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
    Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
    JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inconsistency and features of single nucleotide variants detected in whole exome sequencing versus transcriptome sequencing: A case study in lung cancer.
    O'Brien TD; Jia P; Xia J; Saxena U; Jin H; Vuong H; Kim P; Wang Q; Aryee MJ; Mino-Kenudson M; Engelman JA; Le LP; Iafrate AJ; Heist RS; Pao W; Zhao Z
    Methods; 2015 Jul; 83():118-27. PubMed ID: 25913717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer.
    Liu Y; Kheradmand F; Davis CF; Scheurer ME; Wheeler D; Tsavachidis S; Armstrong G; Simpson C; Mandal D; Kupert E; Anderson M; You M; Xiong D; Pikielny C; Schwartz AG; Bailey-Wilson J; Gaba C; De Andrade M; Yang P; Pinney SM; ; Amos CI; Spitz MR
    J Thorac Oncol; 2016 Jan; 11(1):52-61. PubMed ID: 26762739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of copy number variation detection tools for cancer using whole exome sequencing data.
    Zare F; Dow M; Monteleone N; Hosny A; Nabavi S
    BMC Bioinformatics; 2017 May; 18(1):286. PubMed ID: 28569140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candidate gene discovery in autoimmunity by using extreme phenotypes, next generation sequencing and whole exome capture.
    Johar AS; Anaya JM; Andrews D; Patel HR; Field M; Goodnow C; Arcos-Burgos M
    Autoimmun Rev; 2015 Mar; 14(3):204-9. PubMed ID: 25447288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.